These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7002427)

  • 21. Quantitative effects of timolol and hydrochlorothiazide on blood pressure, heart rate and plasma renin activity: results of a double-blind factorial trial in patients with essential hypertension.
    Chalmers JP; Horvath JS; Korner PI; Tiller DJ; Bune AJ; England JD; Fletcher PJ
    Clin Sci Mol Med Suppl; 1976 Dec; 3():517s-519s. PubMed ID: 799560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a fixed combination of timolol maleate, hydrochlorothiazide and amiloride hydrochloride in the treatment of hypertension: A long-term multicentre trial.
    Pittaway D
    S Afr Med J; 1980 Aug; 58(6):231-5. PubMed ID: 6996156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of timolol plus hydrochlorothiazide plus amiloride and methyldopa in essential hypertension in Black Africans.
    Obel AO
    Trop Geogr Med; 1983 Sep; 35(3):285-91. PubMed ID: 6649055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Behavior of renin, aldosterone, electrolytes and extracellular spaces during combination diuretic therapy in hypertensive patients].
    Hilfenhaus M; Erbler HC; Mariss P; Liebau H
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():299-302. PubMed ID: 611970
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of timolol and hydrochlorothiazide on blood-pressure and plasma renin activity. Double-blind factorial trial.
    Chalmers J; Tiller D; Horvath J; Bune A
    Lancet; 1976 Aug; 2(7981):328-31. PubMed ID: 60566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A general practice study of timolol/hydrochlorothiazide/amiloride ('Moducren'), a new therapy for hypertension, and the doctor's influence on management.
    Parry EE; Arr S; Tait D
    Pharmatherapeutica; 1983; 3(5):294-9. PubMed ID: 6844366
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of a field study with Moducrin in 12596 hypertensive patients].
    Bergis K
    Med Welt; 1979 Nov; 30(46):1733-7. PubMed ID: 537497
    [No Abstract]   [Full Text] [Related]  

  • 28. Dissociation between renin and aldosterone during chronic diuretic therapy. Effect of the addition of a beta blocker, timolol.
    Lebel M; Grose JH; Belleau LJ
    J Clin Pharmacol; 1979; 19(8-9 Pt 1):424-7. PubMed ID: 489761
    [No Abstract]   [Full Text] [Related]  

  • 29. A multiclinic double-blind comparison of timolol and hydrochlorothiazide alone and in combination in th e treatment of essential hypertension.
    Leon AS; Hunninghake DB
    J Clin Pharmacol; 1983 Jan; 23(1):5-15. PubMed ID: 6341417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potassium sparing by amiloride during thiazide therapy in hypertension.
    Andersson PO; H-Andersen H; Hagman A; Henning R
    Clin Pharmacol Ther; 1984 Aug; 36(2):197-200. PubMed ID: 6744778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of a fixed ratio combination of hydrochlorothiazide, amiloride and timolol ('Moducren') given once versus twice daily in mild to moderate hypertension.
    Young JH; VandenBurg MJ; Isitt VL; Currie WJ
    Pharmatherapeutica; 1984; 4(1):64-8. PubMed ID: 6504947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Reliable lowering of blood pressure with one tablet of Moducrin daily (author's transl)].
    Knauf H; Steim H
    MMW Munch Med Wochenschr; 1980 Jan; 122(4):133-6. PubMed ID: 6767937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Moducrin--a new combined preparation in the treatment of hypertension (author's transl)].
    Prachar H; Nobis H; Pollak H; Enenkel W
    Wien Klin Wochenschr; 1981 Aug; 93(15):489-92. PubMed ID: 7303690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum potassium and uric acid changes during treatment with timolol alone and in combination with a diuretic.
    Pedersen OL; Mikkelsen E
    Clin Pharmacol Ther; 1979 Sep; 26(3):339-43. PubMed ID: 380867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amiloride with or without salbutamol versus placebo: effects on lipoproteins in hypertensive patients treated with timolol-hydrochlorothiazide.
    Spence JD; Wong DG
    J Hypertens Suppl; 1986 Dec; 4(5):S515-8. PubMed ID: 3553482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronism.
    Griffing GT; Melby JC
    Clin Exp Hypertens A; 1983; 5(6):779-801. PubMed ID: 6309436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antihypertensive effect of a fixed beta-receptor blockader-diuretic combination during a single daily administration].
    Overlack A; Stumpe KO
    Med Welt; 1978 Sep; 29(39):1517-20. PubMed ID: 357884
    [No Abstract]   [Full Text] [Related]  

  • 38. A controlled study of the antihypertensive effect of carteolol, a new beta-adrenergic receptor blocking drug, in combination with hydrochlorothiazide and amiloride.
    Tarkiainen A; Saraste K; Seppälä T; Gordin A; Auvinen J
    Eur J Clin Pharmacol; 1981 Mar; 19(4):239-44. PubMed ID: 6116605
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparative study of Moducren and Moduretic and their effect on plasma potassium in essential hypertension.
    Jaffé G; Grimshaw JJ; Vallé-Jones JC; Warnock JM
    Practitioner; 1982 Feb; 226(1364):355-8. PubMed ID: 7088834
    [No Abstract]   [Full Text] [Related]  

  • 40. Multiclinic comparison of amiloride, hydrochlorothiazide, and hydrochlorothiazide plus amiloride in essential hypertension. Multicenter Diuretic Cooperative Study Group.
    Arch Intern Med; 1981 Mar; 141(4):482-6. PubMed ID: 7011237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.